Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 16 January 2020


Cancer care in Europe: Where are we in 2020?

Cancer care in Europe: Where are we in 2020?

The Comparator Report on Cancer in Europe, launched today, provides an overview of the current state of cancer care in Europe. Developed by the Swedish Institute for Health Economics, it reflects on major trends in cancer across Europe, including patient outcomes, disease burden and patient access to care and treatment as well as potential solutions to tackle cancer.

Among the key findings of report is what looks like a paradox: although more people are being diagnosed with cancer, a smaller proportion of those people appear to be dying from the disease.

Read more




Medicines shortages – from assumptions to evidence to action
15 January 2020 - Nathalie Moll

Addressing the issue of shortages is a priority for the research-based industry in Europe as well as for supply chain... Read more




Cancer care in Europe: Where are we in 2020?
29 January 2020 (Brussels, Belgium)

Discussion on the key findings of the Comparator Report on Cancer in Europe Read more

POSTPONED - China/EU Pharmaceutical Industry Forum
16 March 2020 (Wavre, Belgium)

** Event postponed until Autumn 2020 ** Read more


Animal welfare

The pharmaceutical industry works to implement 3Rs to ensure high animal welfare and high quality science. We strive to go beyond what is legally required and ultimately improve the lives of the people and animals that stand to benefit from the research. Here are our latest publications:


Putting animal welfare principles and 3Rs into action
16 January 2020 (Publications)

This newly released leaflet showcases concrete examples leading to improved animal welfare and high-quality science.... Read more

Assessing and benchmarking ‘Culture of Care’ in the context of using animals for scientific...
16 January 2020 (Publications)

EFPIA and our Animal Welfare group has developed a framework to help organizations identify gaps or potential areas... Read more


What we are reading


Janssen Signs Six More Data Partners To Its Haematology Outcomes Network In Europe (HONEUR)...
On 15 January 2020 (

With these partners joining HONEUR, the network now comprises 49 data partners with information on more than 13,000... Read more

AMR Industry Alliance 2020 report launches on 16 January 2020
On 16 January 2020 (

The report outlines a forward-looking agenda listing the next steps which the Alliance is committed to take. Read more